Follow us on:

Linkedin Facebook

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Legal & General

Legal & General sets out refreshed strategy and financial targets in Capital Markets event

Legal & General Group Plc (LON:LGEN) unveils a strategic plan for sustainable growth, enhanced returns, and a sharper focus on core divisions. CEO António Simões outlines the vision at a Capital Markets Event...
SEGRO plc

SEGRO Plc hosting Investor & Analyst Event today on “Defining the Urban Warehouse Opportunity”

Join SEGRO plc at the Investor & Analyst Event on "Defining the Urban Warehouse Opportunity" in London. Learn about their unique urban assets and market-leading platform. CEO David Sleath will kick off the event with insightful presentations and panels...
GSK

GSK starts appeal process of recent Delaware Daubert decision

GSK seeks appeal of recent Daubert ruling in Zantac litigation in Delaware Superior Court. Scientific consensus disputes claim of increased cancer risk...
GSK plc

GSK’s Arexvy RSV vaccine approved for adults 50-59 at risk of LRTD

GSK secures FDA approval for Arexvy in adults aged 50-59 at increased risk for RSV-LRTD. Clinical development ongoing, expanding vaccine benefits globally...
Broker Ratings

Marathon Oil Corporation Share Price Target ‘$34.00’, now 21.9% Upside Potential

Broker Ratings

Smiths Group plc 25.9% potential upside indicated by Jefferies

Broker Ratings

Anglo American plc 26.3% potential upside indicated by Citigroup

Broker Ratings

Fresnillo Plc 39.4% potential upside indicated by JP Morgan

Broker Ratings

Weir Group PLC 24.5% potential upside indicated by Berenberg Bank

Broker Ratings

Sage Group PLC -7.4% potential downside indicated by Canaccord Genuity

Broker Ratings

Intertek Group plc 5.2% potential upside indicated by RBC Capital Markets

AstraZeneca

AstraZeneca completes acquisition of Fusion Pharmaceuticals

AstraZeneca completes acquisition of Fusion Pharmaceuticals, enhancing its oncology portfolio with next-gen radioconjugates. Learn more here...
B&M

B&M European Value Retail reports strong FY24 financial results & dividend increase

B&M European Value Retail S.A. (LON:BME) reports strong FY24 financial results with revenue growth and profit increase, setting the stage for future growth...
Centrica plc

Centrica Plc provides Trading Update ahead of 2024 interim results

Centrica plc (LON:CNA) provides an update on its trading performance ahead of its 2024 Interim Results. Read on for details on the company's strong performance and strategic initiatives...
LondonMetric Property

LondonMetric Property Plc to sell two offices in Scotland for £36.6 million

LondonMetric Property Plc (LON:LMP) announces sale of two offices in Scotland for £36.6 million, continuing strategy to exit non-core assets. Chief Executive Andrew Jones provides insight...
British American Tobacco plc

British American Tobacco plc on track for FY guidance with strong H2 acceleration

British American Tobacco plc (LON:BATS) has shared its latest trading statement, highlighting progress towards FY24 guidance and strategic investments for sustainable growth. CEO Tadeu Marroco details the company's performance and outlook for the future. #BAT #tradingstatement..
AstraZeneca

AstraZeneca Plc Tagrisso recommended for approval in the EU for NSCLC treatment

AstraZeneca's Tagrisso recommended EU approval for 1st-line treatment of EGFRm NSCLC with positive results from FLAURA2 trial published in NEJM...
GSK

GSK Plc Second trial to show robust efficacy for a Blenrep combination

GSK plc announces positive results from DREAMM-8 trial at ASCO 2024, showing significant improvements in PFS for Blenrep combination therapy...
Frasers Group

Frasers Group increases its investment in Hugo Boss

Frasers Group increases investment in Hugo Boss, now holding 2.47% of common stock and 13.92% via put options, with an exposure of €360m...
JD Sports

JD Sports Fashion outperformed the market delivering organic sales growth of 9%

Discover JD Sports Fashion Plc's strong financial performance and strategic progress in their full year unaudited results for FY24, as CEO Régis Schultz shares insights...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

September 11, 2025

Legal & General

Legal & General sets out refreshed strategy and financial targets in Capital Markets event

Legal & General Group Plc (LON:LGEN) unveils a strategic plan for sustainable growth, enhanced returns, and a sharper focus on core divisions. CEO António Simões outlines the vision at a Capital Markets Event...
SEGRO plc

SEGRO Plc hosting Investor & Analyst Event today on “Defining the Urban Warehouse Opportunity”

Join SEGRO plc at the Investor & Analyst Event on "Defining the Urban Warehouse Opportunity" in London. Learn about their unique urban assets and market-leading platform. CEO David Sleath will kick off the event with insightful presentations and panels...
GSK

GSK starts appeal process of recent Delaware Daubert decision

GSK seeks appeal of recent Daubert ruling in Zantac litigation in Delaware Superior Court. Scientific consensus disputes claim of increased cancer risk...
GSK plc

GSK’s Arexvy RSV vaccine approved for adults 50-59 at risk of LRTD

GSK secures FDA approval for Arexvy in adults aged 50-59 at increased risk for RSV-LRTD. Clinical development ongoing, expanding vaccine benefits globally...
Broker Ratings

Marathon Oil Corporation Share Price Target ‘$34.00’, now 21.9% Upside Potential

Broker Ratings

Smiths Group plc 25.9% potential upside indicated by Jefferies

Broker Ratings

Anglo American plc 26.3% potential upside indicated by Citigroup

Broker Ratings

Fresnillo Plc 39.4% potential upside indicated by JP Morgan

Broker Ratings

Weir Group PLC 24.5% potential upside indicated by Berenberg Bank

Broker Ratings

Sage Group PLC -7.4% potential downside indicated by Canaccord Genuity

Broker Ratings

Intertek Group plc 5.2% potential upside indicated by RBC Capital Markets

AstraZeneca

AstraZeneca completes acquisition of Fusion Pharmaceuticals

AstraZeneca completes acquisition of Fusion Pharmaceuticals, enhancing its oncology portfolio with next-gen radioconjugates. Learn more here...
B&M

B&M European Value Retail reports strong FY24 financial results & dividend increase

B&M European Value Retail S.A. (LON:BME) reports strong FY24 financial results with revenue growth and profit increase, setting the stage for future growth...
Centrica plc

Centrica Plc provides Trading Update ahead of 2024 interim results

Centrica plc (LON:CNA) provides an update on its trading performance ahead of its 2024 Interim Results. Read on for details on the company's strong performance and strategic initiatives...
LondonMetric Property

LondonMetric Property Plc to sell two offices in Scotland for £36.6 million

LondonMetric Property Plc (LON:LMP) announces sale of two offices in Scotland for £36.6 million, continuing strategy to exit non-core assets. Chief Executive Andrew Jones provides insight...
British American Tobacco plc

British American Tobacco plc on track for FY guidance with strong H2 acceleration

British American Tobacco plc (LON:BATS) has shared its latest trading statement, highlighting progress towards FY24 guidance and strategic investments for sustainable growth. CEO Tadeu Marroco details the company's performance and outlook for the future. #BAT #tradingstatement..
AstraZeneca

AstraZeneca Plc Tagrisso recommended for approval in the EU for NSCLC treatment

AstraZeneca's Tagrisso recommended EU approval for 1st-line treatment of EGFRm NSCLC with positive results from FLAURA2 trial published in NEJM...
GSK

GSK Plc Second trial to show robust efficacy for a Blenrep combination

GSK plc announces positive results from DREAMM-8 trial at ASCO 2024, showing significant improvements in PFS for Blenrep combination therapy...
Frasers Group

Frasers Group increases its investment in Hugo Boss

Frasers Group increases investment in Hugo Boss, now holding 2.47% of common stock and 13.92% via put options, with an exposure of €360m...
JD Sports

JD Sports Fashion outperformed the market delivering organic sales growth of 9%

Discover JD Sports Fashion Plc's strong financial performance and strategic progress in their full year unaudited results for FY24, as CEO Régis Schultz shares insights...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple